Role of putative membrane receptors in the effects of estradiol on human vascular cell growth

American Journal of Hypertension

Volumn 17, Issue 5, 2004, Pages 462-469

  Somjen, Dalia ^a   Kohen, Fortune ^b   Gayer, Batya ^b   Sharon, Orly ^a   Baz, Merav ^d   Limor, Rona ^a   Kulik, Tikva ^b   Knoll, Esther ^a   Stern, Naftali ^a,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d NONE

Author keywords

Endothelial cells; Estrogen; Membrane binding sites; Vascular smooth muscle cells

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 6 CARBOXYMETHYLGENISTEIN; ALBUMIN; CREATINE KINASE; ESTRADIOL; ESTRADIOL 17BETA 6 O CARBOXYMETHYL OXIME; FLUORESCENT DYE; GENISTEIN; KEYHOLE LIMPET HEMOCYANIN; MEMBRANE RECEPTOR; METHYL GROUP; MITOGEN ACTIVATED PROTEIN KINASE; OXIME DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL GROWTH; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; ESTROGEN ACTIVITY; FLUORESCENCE; HUMAN; HUMAN CELL; MEMBRANE BINDING; MOLECULAR INTERACTION; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN BINDING; VASCULAR SMOOTH MUSCLE;

BUTADIENES; CELL DIVISION; CELLS, CULTURED; CREATINE KINASE; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NITRILES; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 1942500985     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2004.01.002     Document Type: Article

References (24)

1. Ropero A.B., Soria B., Nadal A. A nonclassical estrogen membrane receptor triggers rapid differential actions in the endocrine pancreas. Mol Endocrinol. 16:2002;497-505.
2. Sylvia V.L., Walton J., Lopez D., Dean D.D., Boyan B.D., Schwartz Z. 17 beta-estradiol-BSA conjugates and 17 beta-estradiol regulate growth plate chondrocytes by common membrane associated mechanisms involving PKC dependent and independent signal transduction. J Cell Biochem. 81:2001;413-429.
3. Nadal A., Ropero A.B., Laribi O., Maillet M., Fuentes E., Soria B. Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor alpha and estrogen receptor beta. Proc Natl Acad Sci USA. 97:2000;11603-11608.
4. Gilligan D.M., Badar D.M., Panza J.A., Quyyumi A.A., Cannon R.O. III. Acute vascular effects of estrogen in postmenopausal women. Circulation. 90:1994;786-791.
5. Pines A., Averbuch M., Fisman E.Z., Rosano G.M. The acute effects of sublingual 17beta-estradiol on the cardiovascular system. Maturitas. 33:1999;81-85.
6. Chambliss K.L., Yuhanna I.S., Mineo C., Liu P., German Z., Sherman T.S., Mendelsohn M.E., Anderson R.G., Shaul P.W. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signalling module in caveolae. Circ Res. 87:2000;E44-E52.
7. Hisamoto K., Ohmichi M., Kurachi H., Hayakawa J., Kanda Y., Nishio Y., Adachi K., Tasaka K., Miyoshi E., Fujiwara N., Taniguchi N., Murata Y. Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem. 276:2001;3459-3467.
8. Lu Q., Ebling H., Mittler J., Baur W.E., Kaeas R.H. MAP kinase mediates growth factor-induced nuclear translocation of estrogen receptor alpha. FEBS Lett. 516:2000;1-8.
9. Vargas R., Wroblewska B., Rego A., Hatch J., Ramwell P.W. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol. 109:1993;612-617.
10. Somjen D., Kohen F., Jaffe A., Amir-Zaltsman Y., Knoll E., Stern N. Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells. Hypertension. 32:1998;39-45.
11. Chen S.J., Li H., Durand J., Oparil S., Chen Y.F. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation. 93:1996;577-584.
12. Sullivan T.R., Karas R.H., Aronovitz M., Faller G.T., Ziar J.P., Smith O'Dunnel T.F., Mendelson M.E. Estrogen inhibits the response to injury in a mouse carotid artery model. J Clin Invest. 96:1995;2482-2488.
13. Karas R.H., Hodgin J.B., Kwoun M., Krege J.H., Aronovitz M., Mackey W., Gustafsson J.A., Korach K.S., Smithies O., Mendelsohn M.E. Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice. Proc Natl Acad Sci USA. 96:1999;15133-15136.
14. Pare G., Krust A., Karas R.H., Dupont S., Aronovitz M., Chambon P., Mendelsohn M.E. Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury. Circ Res. 90:2002;1087-1092.
15. Somjen D., Kohen F., Amir-Zaltsman Y., Knoll E., Stern N. Vitamin D analogs modulate the action of gonadal steroids in human vascular cells in vitro. Am J Hypertens. 13:2000;396-404.
16. Somjen D., Knoll E., Kohen F., Stern N. Effects of phytoestrogens on DNA synthesis and creatine kinase activity in vascular cells. Am J Hypertens. 14:2001;1256-1266.
17. Somjen D, Paller CJ, Gayer B, Kohen F, Knoll E, Stern N: High glucose blocks the effects of estradiol on human vascular smooth muscle cell growth: differential interaction with estradiol and raloxifene. J Steroid Biochem Mol Biol 2004;88:101-110
18. Kohen F., Bauminger S., Lindner H. Preparation of antigenic steroid-protein conjugates. Cameron E.D.H., Hillier S.G., Griffiths K. Steroid Immunoassay. 1975;11-31 Alpha Omega Publishing, Cardiff.
19. Kohen F., Lichter S., Gayer B., DeBovere J., Lu L.J. The measurement of the isoflavone daidzein by time resolved fluorescent immunoassay a method for assessment of dietary Soya exposure. J Steroid Biochem Mol Biol. 64:1998;217-222.
20. Kohen F., Gayer B., Amir-Zaltsman Y., Ben-Hur H., Thomas E., Lu L.J. A nonisotopic enzyme-based immunoassay for assessing human exposure to genistein. Nutr Cancer. 35:1999;96-103.
21. Crabbe P., Van Peteghem C., Salden M., Kohen F. Influence of the hapten conjugation site on the characteristics of antibodies generated against metabolites of clostebol acetate. J Agric Food Chem. 48:2000;3633-3638.
22. Limor R., Weisinger G., Gilad S., Knoll E., Sharon O., Jaffe A., Kohen F., Berger E., Lifshizt B., Stern N. A novel form of platelet type 12-lipoxygenase mRNA in human vascular smooth muscle cells. Hypertension. 38:2001;864-871.
23. Amir-Zaltsman Y., Mazor O., Gayer B., Scherz A., Salomon Y., Kohen F. Inhibitors of protein tyrosine phosphorylation preliminary assessment of activity by time-resolved fluorescence. Luminescence. 15:2000;377-380.
24. Rutherford T, Brown WD, Sopi E, Aschkenazi S, Munoz A, Mor G: Absence of estrogen-receptor-beta expression in metastatic ovarian cancer. Obstet Gynecol 2000;96:417-421